Edwards Lifesciences EW has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

This was the stock's second consecutive day of losses.

This was the stock's third consecutive day of losses.

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).

Edwards Lifesciences Corp. released new economic and clinical data on severe aortic stenosis (AS) demonstrating intervening in a patient with the disease before symptoms develop can reduce costs to ...

Bill Baruch, founder & president at Blue Line Capital, joins CNBC’s 'Halftime Report' to detail his latest buy.

The study found that early intervention led to an 80% reduction in heart failure hospitalisations one year after treatment.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Timberwolves thought they were dealt a seismic injury blow one quarter into their Western Conference Finals duel with the Thunder when star guard Anthony Edwards went down with an apparent ...